Novo Nordisk A/S Rotten Score Breakdown
💼Corporate Misconduct
Rotten to the core
Avg Rating: 5.00Ratings: 1Severity Score: 6.00Evidence Count: 1Contribution: 30.0 pts
Misconduct: low 0 · medium 0 · high 1
Remediation: low 0 · medium 0 · high 0ⓘ cap: 25%
Novo Nordisk USD 58.65 million Victoza REMS and False Claims settlement
Novo Nordisk agreed to pay USD 58.65 million in 2017 to resolve U.S. allegations that its U.S. subsidiary failed to comply with an FDA-mandated Risk Evaluation and Mitigation Strategy for the diabetes drug Victoza and related False Claims Act allegations. The resolution included USD 12.15 million in disgorgement tied to alleged FDCA violations from 2010 to 2012 and USD 46.5 million relating to alleged False Claims Act violations from 2010 to 2014. Source: https://www.justice.gov/archives/opa/pr/novo-nordisk-agrees-pay-58-million-failure-comply-fda-mandated-risk-program
📰Human Rights & Exploitation
No documented evidence
Avg Rating: —Ratings: 0Severity Score: 0.00Evidence Count: 0Contribution: 0.0 pts
🎭Fraud & Corruption
No documented evidence
Avg Rating: —Ratings: 0Severity Score: 0.00Evidence Count: 0Contribution: 0.0 pts
🧪Deceptive Practices
No documented evidence
Avg Rating: —Ratings: 0Severity Score: 0.00Evidence Count: 0Contribution: 0.0 pts
🚨Environmental Harm
No documented evidence
Avg Rating: —Ratings: 0Severity Score: 0.00Evidence Count: 0Contribution: 0.0 pts
🌱Sustainability Deception
No documented evidence
Avg Rating: —Ratings: 0Severity Score: 0.00Evidence Count: 0Contribution: 0.0 pts
💸Workplace Misconduct
No documented evidence
Avg Rating: —Ratings: 0Severity Score: 0.00Evidence Count: 0Contribution: 0.0 pts
⚠️Financial Misconduct
No documented evidence
Avg Rating: —Ratings: 0Severity Score: 0.00Evidence Count: 0Contribution: 0.0 pts